Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: No progression to clonal hematopoiesis or leukemia

Molecular Therapy

Volumn 9, Issue 3, 2004, Pages 389-395

  Kiem, Hans Peter ^a   Sellers, Stephanie ^b   Thomasson, Bobbie ^a   Morris, Julia C ^a   Tisdale, John F ^c   Horn, Peter A ^a   Hematti, Peiman ^b   Adler, Rima ^b   Kuramoto, Ken ^b   Calmels, Boris ^b   Bonifacino, Aylin ^b   Hu, Jiong ^b   von Kalle, Christof ^d,e   Schmidt, Manfred ^d,e   Sorrentino, Brian ^f   Nienhuis, Arthur ^f   Blau, C Anthony ^a   Andrews, Robert G ^a   Donahue, Robert E ^b   Dunbar, Cynthia E ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF FREIBURG   (Germany)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CD34 ANTIGEN; CELL DNA; DIHYDROFOLATE REDUCTASE; GREEN FLUORESCENT PROTEIN; KANAMYCIN KINASE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MULTIDRUG RESISTANCE PROTEIN 1; RETROVIRUS VECTOR; VIRUS DNA; YELLOW FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; CLINICAL PROTOCOL; CLONAL VARIATION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DISEASE COURSE; DOG; DRUG RESISTANCE; FOLLOW UP; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; INFUSION; LEUKEMIA; LEUKEMOGENESIS; LONG TERM CARE; MARKER GENE; MOLECULAR BIOLOGY; MOLECULAR CLONING; NONHUMAN; RHESUS MONKEY; STANDARDIZATION; TRANSGENE; VIRUS DNA CELL DNA INTERACTION; VIRUS REPLICATION;

ANIMALIA; CANIS FAMILIARIS; MACACA; MACACA MULATTA; PAPIO; PRIMATES;

EID: 12144289202     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2003.12.006     Document Type: Article

References (35)

1. Hacein-Bey-Abina, S., et al. (2002). Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346: 1185-1193.
2. Aiuti, A., et al. (2002). Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296: 2410-2413.
3. Hacein-Bey-Abina, S., et al. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419.
4. Hacein-Bey-Abina, S., et al. (2003). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348: 255-256.
5. Kohn, D. B., Sadelain, M., and Glorioso, J. C. (2003). Occurrence of leukaemia following gene therapy of X-linked SCID. Nat. Rev. Cancer 3: 477-488.
6. Li, Z., et al. (2002). Murine leukemia induced by retroviral gene marking. Science 296: 497.
7. Kohn, D. B., et al. (2003). American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Mol. Ther. 8: 180-187.
8. Donahue, R. E., and Dunbar, C. E. (2001). An update on the use of non-human primate models for preclinical testing of gene therapy approaches targeting hematopoietic cells. Hum. Gene Ther. 12: 607-617.
9. Schmidt, M., et al. (2002). Polyclonal long-term repopulating stem cell clones in a primate model. Blood 100: 2737-2743.
10. Shi, P., Hematti, P., von Kalle, C., and Dunbar, C. (2002). Genetic marking as an approach to studying in vivo hematopoiesis: progress in the non-human primate model. Oncogene 21: 3274-3283.
11. Bunting, K. D., Galipeau, J., Topham, D., Benaim, E., and Sorrentino, B. P. (1998). Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 92: 2269-2279.
12. Moscow, J. A., et al. (1999). Effect of MDR1 gene transduction on engraftment and expansion of hematopoietic progenitor cells during breast cancer chemotherapy. Blood 94: 52-61.
13. Sellers, S. E., et al. (2001). The effect of multidrug-resistance 1 gene versus neo transduction on ex vivo and in vivo expansion of rhesus macaque hematopoietic repopulating cells. Blood 97: 1888-1891.
14. Tisdale, J. F., et al. (1998). Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 92: 1131-1141.
15. Kiem, H. P., et al. (1998). Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood 92: 1878-1886.
16. Takatoku, M., et al. (2001). Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates. J. Clin. Invest. 108: 447-455.
17. Wu, T., et al. (2000). Prolonged high-level detection of retrovirally-marked hematopoietic cells in non-human primates after transduction of CD34+ progenitors using clinically feasible methods. Mol. Ther. 1: 285-293.
18. Kurre, P., et al. (2001). Gene transfer into baboon repopulating cells: A comparison of Flt-3 ligand and megakaryocyte growth and development factor versus IL-3 during ex vivo transduction. Mol. Ther. 3: 920-927.
19. Horn, P. A., Topp, M. S., Morris, J. C., Riddell, S. R., and Kiem, H.-P. (2002). Highly efficient gene transfer into baboon repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells. Blood 100: 3960-3967.
20. + blood cells is superior to G-CSF or G-CSF-flt3L mobilized cells in non-human primates. Blood 101: 2199-2205.
21. Tisdale, J. F., and Dunbar, C. E. (2002). Plasticity and hematopoiesis: Circe's transforming potion? Curr. Opin. Hematol. 9: 268-273.
22. Hu, J., et al. (2003). Direct comparison of RD114-pseudotyped versus amphotropic pseudotyped retroviral vectors for transduction of rhesus macaque long-term repopulating cells. Mol. Ther. 8: 611-617.
23. Neff, T., et al. (2002). Pharmacologically regulated in vivo selection in a large animal. Blood 100: 2026-2031.
24. Goerner, M., et al. (1999). The use of granulocyte colony-stimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs. Blood 94: 2287-2292.
25. Kiem, H. P., et al. (1999). Improved gene transfer into canine hematopoietic repopulating cells using CD34-enriched marrow cells in combination with a gibbon ape leukemia virus-pseudotype retroviral vector. Gene Ther. 6: 966-972.
26. Goerner, M., et al. (2001). Sustained multilineage gene persistence and expression in dogs transplanted with CD34(+) marrow cells transduced by RD114-pseudotype oncoretrovirus vectors. Blood 98: 2065-2070.
27. Horn, P. A., et al. (2002). Efficient lentiviral gene transfer to canine hematopoietic repopulating cells using an overnight transduction protocol. Blood 100: 687a.
28. Baum, C., et al. (2003). Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101: 2099-2114.
29. Wu, X., Li, Y., Crise, B., and Burgess, S. M. (2003). Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749-1751.
30. Donahue, R. E., et al. (1992). Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176: 1125-1135.
31. Suzuki, T., et al. (2002). New genes involved in cancer identified by retroviral tagging. Nat. Genet. 32: 166-174.
32. Abkowitz, J. L., Catlin, S. N., and Guttorp, P. (1996). Evidence that hematopoiesis may be a stochastic process in vivo. Nat. Med. 2: 190-196.
33. Moolten, F. L., and Cupples, L. A. (1996). A model for predicting the risk of cancer consequent to retroviral gene therapy. Hum. Gene Ther. 3: 479-486.
34. Kelly, P. F., et al. (2002). Prolonged multilineage clonal hematopoiesis in a rhesus recipient of CD34 positive cells marked with an oncoretroviral vector. Blood Cells Mol. Dis. 30: 132-143.
35. + marrow cells engraft lethally irradiated baboons. J. Clin. Invest. 81: 951-955.